Drug
Exoenzyme C3, Clostridium botulinum clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 1
- first study started
- 2005
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
2 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
BioAxone BioSciences, Inc. (2) · Vertex Pharmaceuticals Incorporated (1)
Studies
Open first, then newest update. How each study uses exoenzyme C3, Clostridium botulinum is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord InjuriesCompletedPhase 1/2Vertex Pharmaceuticals IncorporatedNCT00500812Written as Cethrin
- Cethrin in Acute Cervical Spinal Cord InjuryWithdrawnPhase 2/3BioAxone BioSciences, Inc.NCT02053883Written as Cethrin (BA-210)
- Safety and Efficacy of Cethrin® in Adult Subjects With Acute Cervical Spinal Cord InjuryWithdrawnPhase 2BioAxone BioSciences, Inc.NCT00610337Written as Cethrin® (BA-210)